Abstract
Senile dementia of the Alzheimer's type can be diagnosed with certainty only by examining neurofibrillary tangles and neuritic plaques under the microscope1–4. Recently, it has been suggested that the condition is linked to specific neurotransmitter systems5, with a decline of cortical acetylcholine, choline acetyl-transferase5–8, cholinergic neurones projecting to the cortex9–11, cortical noradrenaline content12, locus coeruleus neurones13,14 and cortical somatostatic content15. Using immunocytochemical methods16, we here report that somatostatin-immunoreactive processes are present in neuritic plaques in human Alzheimer's specimens17. These data, as well as other reports of non-cholinergic changes18,19, strongly imply that Alzheimer's disease cannot be linked exclusively to cortical cholinergic elements, as proposed previously8. Rather, our data on plaque and somatostatin co-localization and distribution patterns suggest that Alzheimer's neuropathology may involve primarily the loss of selective cortical neurones that are targets of the implicated transmitter systems and that plaque formation may result from the degeneration of presynaptic and postsynaptic neurites of large projection neurones in layers III and V. Given the neurochemically heterogeneous input to these cells, it is not surprising that several neutrotransmitter systems, one of which is somatostatin, are implicated in the pathology of Alzheimer's disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Katzman, R. Archs Neurol. 33, 217–218 (1976).
Terry, R. D. & Davies, P. A. Rev. Neurosci. 3, 77–95 (1980).
Blessed, G., Tomlinson, B. E. & Roth, M. Brit. J. Psychol. 114, 797–811 (1968).
Roth, M., Tomlinson, B. E. & Blessed, G. Proc. R. Soc. Med. 60, 14–18 (1967).
Rossor, M. N. Lancet ii, 200 (1982).
Rossor, M. N., Iversen, L. L., Reynolds, G. P., Mountjoy, C. Q. & Roth, M. Br. Med. J. 288, 961 (1984).
Davies, P. & Maloney, A. J. R. Lancet ii, 1403 (1976).
Coyle, J. T., Price, D. L. & DeLong, M. R. Science 219, 1184–1190 (1983).
Cuello, A. C. & Sofroniew, M. V. Trends Neurosci. 7, 74–78 (1984).
Whitehouse, P. J. et al. Science 215, 1237–1239 (1982).
Struble, R. G., Cork, L. C., Whitehouse, P. J. & Price, D. L. Science 216, 413–415 (1982).
Adolfsson, R., Gottfries, C. G., Roos, B. E. & Winblad, B. Br. J. Psychiat. 135, 216 (1979).
Bondareff, W., Mountjoy, C. Q. & Roth, M. Neurology 32, 164 (1982).
Iversen, L. L. et al. Neurosci. Lett. 39, 95 (1983).
Davies, P., Katzman, R. & Terry, R. D. Nature 288, 279 (1980).
Morrison, J. H., Benoit, R., Magistretti, P. J. & Bloom, F. E. Brain Res. 262, 344–351 (1983).
Morrison, J. H., Rogers, J., Scherr, S. H., Benoit, R. & De Girolami, U. Soc. Neurosci. Abstr. 10, 894 (1984).
Gottfries, C. et al. Neurobiol. Aging 4, 261–272 (1983).
Rogers, J. & Bloom, F. E. in Handbook of the Biology of Aging (eds Finch, C. E. & Schneider, E.) (Van Nostrand Reinhold, New York, in the press).
Benoit, R., Ling, N., Alford, B. & Guillemin, R. Biochem. biophys. Res. Commun. 107, 944–950 (1982).
Schwartz, P. Gerontologia 18, 321(1972).
Sorenson, K. V. Neuroscience 7, 1227–1232 (1982).
Morimatsu, M., Hirai, S., Muramatsu, A. & Yoshikawa, M. J. Am. Geriat. Soc. 23, 390–395 (1975).
Dayan, A. D. Acta neuropath. 16, 85–95 (1970).
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R. & Horoupian, D. S. A. Neurol. 10, 184–192 (1981).
Rogers, J. & Morrison, J. H. J. Neurosci. (submitted).
Jones, E. G. in The Organization of the Cerebral Cortex (eds Schmitt, F. O., Worden, F. G., Adelman, F. & Dennis, S. G.) 199–235 (MIT, Cambridge, 1981).
Armstrong, D. M., Shields, D. & Terry, R. D. Soc. Neurosci. Abstr. 10, 271 (1984).
Mountcastle, V. M. in The Neurosciences—4th Study Program (eds Schmitt, F. O. & Worden, F. G.) 21–42 (MIT, Cambridge, 1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morrison, J., Rogers, J., Scherr, S. et al. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature 314, 90–92 (1985). https://doi.org/10.1038/314090a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/314090a0
This article is cited by
-
Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer’s disease
Scientific Reports (2024)
-
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases
Nature Reviews Neuroscience (2024)
-
Somatostatin slows Aβ plaque deposition in aged APPNL-F/NL-F mice by blocking Aβ aggregation
Scientific Reports (2023)
-
Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders
Molecular Psychiatry (2021)
-
Defining early changes in Alzheimer’s disease from RNA sequencing of brain regions differentially affected by pathology
Scientific Reports (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
